News

Interview with new Managing Director of BIRAC Dr Jitendra Kumar

New bioincubators would be set up to cater to the growth of startup ecosystem including the tier 2 and tier 3 regions

Jul 04, 2023

By : Team ABLE

Serum Institute gets Government of India award for Pneumococcal vaccine

Serum Institute of India was given the Government of India GeM Gaurav Samman for excellent EPI business of its Pneumococcal Conjugate Vaccine (PCV)

Jul 03, 2023

By : Team ABLE

ABLE member Syngene acquires facility from Stelis Biopharma for ? 702 cr

Syngene International, a subsidiary of Biocon Ltd., has decided to acquire a Unit 3 biologics manufacturing facility in Bengaluru from Stelis Biopharma Limited (SBL) on a slump sale basis for a gross value of ?702 crore.

Jul 02, 2023

By : Team ABLE

NCBS launches Rohini Nilekani Centre for Brain and Mind for research on severe mental illnesses

Rohini Nilekani, chairperson of Rohini Nilekani Philanthropies, unveiled the plaque to mark the inauguration of the centre on the NCBS campus. In May this year, Rohini Nilekani Philanthropies announced the grant of Rs 100 crore to the NCBS and the National Institute of Mental Health and Neurosciences (NIMHANS) to set up the centre.

Jul 01, 2023

By : Team ABLE

Regulator approves first Omicron-specific mRNA vaccine from India

Gennova officials say India’s first indigenous mRNA vaccine for the Omicron variant is likely to be rolled out within two to three weeks

Jun 24, 2023

By : Team ABLE